Author Archives: Anthony Deepak DSouza
Recent Posts
- Japan OKs Abecma as 1st CAR T-cell for Heavily Treated Myeloma
- Model May Better Classify Multiple Myeloma and Relapse Risks
- Janssen Seeks FDA Approval of Teclistamab for RRMM
- Xpovio Conditionally Approved in China for Heavily Treated Patients
- Cilta-cel Approval Requested in Japan for Heavily-treated Myeloma